Newly FDA-approved drug nogapendekin alfa inbakicept (Anktiva) needs to be updated

[ratardif]

The FDA approved the drug Anktiva (nogapendekin alfa inbakicept) in April 22, 2024. It needs to be added/updated with the new RxNorm IDs for the ingredients and dosage.

I have provided the RxNorm information below:

Ingredient- nogapendekin alfa inbakicept = RxNorm 2682678
Precise Ingredient- Nogapendekin alfa inbakicept-pmln = RxNorm 2682677
Brand Name- Anktiva = RxNorm 2682686
0.4 ML nogapendekin alfa inbakicept-pmln 1 MG/ML Injection = RxNorm 2682684

Please let me know if you need anything else.
Thank you.
Robin

[TinyRickC137]

Thank you, @ratardif

Vocabularies are updated twice a year, therefore, we can't include the latest versions - there will always be a small delay. The concepts are in RxNorm already, therefore, we will add them to the next release.

[ratardif]

Is there a way to do a manual update on our vocabularies file? We really need these two drugs to be added into our system.

[TinyRickC137]

Yes, @ratardif
You can always add custom concepts to standardized vocabulary tables (concept, concept_synonym, concept_relationship, and, in some edge cases, even concept_ancestor) with a concept_id > 2bil.

We do not recommend this solution in your case since it is related to the concept of curated terminology, already present in Athena.

The next release is planned for February, could you manage it?